Left ventricular and aortic dysfunction in cystic fibrosis mice

Journal of Cystic Fibrosis

Volumn 12, Issue 5, 2013, Pages 517-524

  Sellers, Zachary M ^a,b   Kovacs, Attila ^c   Weinheimer, Carla J ^c   Best, Philip M ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aorta; CFTR; Cystic fibrosis; Left ventricular function

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA DISEASE; AORTA DYSFUNCTION; AORTA FLOW; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DIASTOLE; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART PERFORMANCE; IN VIVO STUDY; MOUSE; NONHUMAN; PULSE WAVE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AORTA; CFTR; CYSTIC FIBROSIS; LEFT VENTRICULAR FUNCTION;

ANIMALS; AORTA; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; MALE; MICE; MUTATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84882811330     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.11.012     Document Type: Article

References (31)

1. Nagel G., Hwang T.C., Nastiuk K.L., Nairn A.C., Gadsby D.C. The protein kinase A-regulated cardiac Cl- channel resembles the cystic fibrosis transmembrane conductance regulator. Nature 1992, 360:81-84.
2. Opie L.H. The heart: physiology, from cell to circulation 1998, Lippencott-Raven, Philadelphia, PA.
3. Duan D.Y., Liu L.L., Bozeat N., Huang Z.M., Xiang S.Y., Wang G.L., et al. Functional role of anion channels in cardiac diseases. Acta Pharmacol Sin 2005, 26:265-278.
4. Kuzumoto M., Takeuchi A., Nakai H., Oka C., Noma A., Matsuoka S. Simulation analysis of intracellular Na+ and Cl- homeostasis during beta 1-adrenergic stimulation of cardiac myocyte. Prog Biophys Mol Biol 2008, 96:171-186.
5. Sellers Z.M., Arcangelis V.D., Xiang Y., Best P.M. Cardiomyocytes with disrupted CFTR function require CaMKII and Ca2+-activated Cl- channel activity to maintain contraction rate. J Physiol 2010, 588:2417-2429.
6. Sellers Z.M., Naren A.P., Xiang Y., Best P.M. MRP4 and CFTR in the regulation of cAMP and beta-adrenergic contraction in cardiac myocytes. Eur J Pharmacol 2012, 681:80-87.
7. Uramoto H., Takahashi N., Dutta A.K., Sabirov R.Z., Ando-Akatsuka Y., Morishima S., et al. Ischemia-induced enhancement of CFTR expression on the plasma membrane in neonatal rat ventricular myocytes. Jpn J Physiol 2003, 53:357-365.
8. Chen H., Liu L.L., Ye L.L., McGuckin C., Tamowski S., Scowen P., et al. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart. Circulation 2004, 110:700-704.
9. Xiang S.Y., Ye L.L., Duan L.L., Liu L.H., Ge Z.D., Auchampach J.A., et al. Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury. Acta Pharmacol Sin 2011, 32:824-833.
10. Solbach T.F., Paulus B., Weyand M., Eschenhagen T., Zolk O., Fromm M.F. ATP-binding cassette transporters in human heart failure. Naunyn Schmiedebergs Arch Pharmacol 2008, 377:231-243.
11. Bright-Thomas R.J., Webb A.K. The heart in cystic fibrosis. J R Soc Med 2002, 95(Suppl. 41):2-10.
12. Mckee A.J., Davies J.C., Aurora P., Muthurangu V., Balfour-Lynn I. Children with cystic fibrosis have increased aortic stiffness as measured by phase contrast magnetic resonance imaging. Pediatr Pulmonol 2012, 354.
13. Hull J.H., Ansley L., Bolton C.E., Sharman J.E., Knight R.K., Cockcroft J.R., et al. The effect of exercise on large artery haemodynamics in cystic fibrosis. J Cyst Fibros 2011, 10:121-127.
14. Hull J.H., Garrod R., Ho T.B., Knight R.K., Cockcroft J.R., Shale D.J., et al. Increased augmentation index in patients with cystic fibrosis. Eur Respir J 2009, 34:1322-1328.
15. Hull J.H., Garrod R., Ho T.B., Knight R.K., Cockcroft J.R., Shale D.J., et al. Dynamic vascular changes following intravenous antibiotics in patients with cystic fibrosis. J Cyst Fibros 2012, 10.1016/j.jcf.2012.07.004.
16. Zeiher B.G., Eichwald E., Zabner J., Smith J.J., Puga A.P., McCray P.B., et al. A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 1995, 96:2051-2064.
17. Zhou L., Dey C.R., Wert S.E., DuVall M.D., Frizzell R.A., Whitsett J.A. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 1994, 266:1705-1708.
18. Rockman H.A., Ross R.S., Harris A.N., Knowlton K.U., Steinhelper M.E., Field L.J., et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A 1991, 88:8277-8281.
19. Ambrosi P., Chazalettes J.P., Viard L., Raynaud M., Faugere G., Noirclerc M., et al. Left ventricular involvement in mucoviscidosis after 2years of age. Arch Fr Pediatr 1993, 50:653-656.
20. Cheron G., Paradis K., Steru D., Demay G., Lenoir G. Cardiac involvement in cystic fibrosis revealed by a ventricular arrhythmia. Acta Paediatr Scand 1984, 73:697-700.
21. Zebrak J., Skuza B., Pogorzelski A., Ligarska R., Kopytko E., Pawlik J., et al. Partial CFTR genotyping and characterisation of cystic fibrosis patients with myocardial fibrosis and necrosis. Clin Genet 2000, 57:56-60.
22. Sellers Z.M., Best P.M. Investigation of left ventricular function in CFTR knockout mice uncovers cardiovascular disturbances independent of lung disease. Pediatr Pulmonol 2010, 33.
23. Duan D.D., Ye L. Novel cardioprotective function of CFTR chloride channels against myocardial hypertrophy and heart failure. Circulation 2011, 124:A18267.
24. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
25. Zhang T., Johnson E.N., Gu Y., Morissette M.R., Sah V.P., Gigena M.S., et al. The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 2002, 277:1261-1267.
26. Ling H., Zhang T., Pereira L., Means C.K., Cheng H., Gu Y., et al. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 2009, 119:1230-1240.
27. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 2008, 70:23-49.
28. Du J., Liu J., Feng H.Z., Hossain M.M., Gobara N., Zhang C., et al. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am J Physiol Heart Circ Physiol 2008, 294:H2604-H2613.
29. Williams S.G., Jackson M., Cooke G.A., Barker D., Patwala A., Wright D.J., et al. How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure?. Am Heart J 2005, 150:983.
30. Nash E.F., Coonar A.S., Stephenson A.L., Delgado D.H., Singer L.G., Tullis E., et al. Cardiac dysfunction in adult CF patients with severe lung disease-a retrospective cohort study. Pediatr Pulmonol 2007, 399.
31. Robert R., Norez C., Becq F. Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl- transport of mouse aortic smooth muscle cells. J Physiol (Lond) 2005, 568:483-495.